These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 15219466

  • 1. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
    Vitiello B, Heiligenstein JH, Riddle MA, Greenhill LL, Fegert JM.
    Biol Psychiatry; 2004 Jul 01; 56(1):3-9. PubMed ID: 15219466
    [Abstract] [Full Text] [Related]

  • 2. Pediatric psychopharmacology.
    Riddle MA, Kastelic EA, Frosch E.
    J Child Psychol Psychiatry; 2001 Jan 01; 42(1):73-90. PubMed ID: 11205625
    [Abstract] [Full Text] [Related]

  • 3. Research interactions between industry and academia: a corporate perspective.
    Citron P.
    Physiologist; 1996 Jun 01; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract] [Full Text] [Related]

  • 4. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB.
    Gastroenterology; 2007 May 01; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract] [Full Text] [Related]

  • 5. The future of pediatric research.
    Boat TF.
    J Pediatr; 2007 Nov 01; 151(5 Suppl):S21-7. PubMed ID: 17950318
    [Abstract] [Full Text] [Related]

  • 6. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ, Wyatt CA, Kleyn DE, Ayad A.
    Drug Discov Today; 2009 Jan 01; 14(1-2):95-101. PubMed ID: 18992364
    [Abstract] [Full Text] [Related]

  • 7. Drug industry in "depression".
    Almog DM.
    Med Sci Monit; 2005 Jan 01; 11(1):SR1-4. PubMed ID: 15614206
    [Abstract] [Full Text] [Related]

  • 8. The promise of South African biotech.
    Akermann B, Kermani F.
    Drug Discov Today; 2006 Nov 01; 11(21-22):962-5. PubMed ID: 17055404
    [No Abstract] [Full Text] [Related]

  • 9. OECD guidelines on open access: commercialization in disguise?
    Hoeyer K, Svendsen MN, Koch L.
    Trends Biotechnol; 2008 Sep 01; 26(9):479-82. PubMed ID: 18684538
    [Abstract] [Full Text] [Related]

  • 10. A status report on neuroscience research, without grade inflation.
    Johnston SC, Hauser SL.
    Ann Neurol; 2006 Dec 01; 60(6):A9-11. PubMed ID: 17192939
    [No Abstract] [Full Text] [Related]

  • 11. What's next in translational medicine?
    Littman BH, Di Mario L, Plebani M, Marincola FM.
    Clin Sci (Lond); 2007 Feb 01; 112(4):217-27. PubMed ID: 17223795
    [Abstract] [Full Text] [Related]

  • 12. Ethical implications of for-profit corporate sponsorship of research.
    Cichy KA.
    SRA J; 1990 Feb 01; 22(1):23-7. PubMed ID: 16047436
    [Abstract] [Full Text] [Related]

  • 13. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.
    Greenhill LL, Vitiello B, Abikoff H, Levine J, March JS, Riddle MA, Capasso L, Cooper TB, Davies M, Fisher P, Findling RL, Fried J, Labellarte MJ, McCracken JT, McMahon D, Robinson J, Skrobala A, Scahill L, Varipatis E, Walkup JT, Zito JM.
    J Am Acad Child Adolesc Psychiatry; 2003 Jun 01; 42(6):651-5. PubMed ID: 12921472
    [Abstract] [Full Text] [Related]

  • 14. What should be done to improve the productivity of neurological research?
    Moses H, Martin JB.
    Ann Neurol; 2006 Dec 01; 60(6):647-51. PubMed ID: 17192925
    [No Abstract] [Full Text] [Related]

  • 15. Research funding. NIH in the post-doubling era: realities and strategies.
    Zerhouni EA.
    Science; 2006 Nov 17; 314(5802):1088-90. PubMed ID: 17110557
    [No Abstract] [Full Text] [Related]

  • 16. Pharmaceutical sciences in 2020.
    Crommelin D, Stolk P, Besançon L, Shah V, Midha K, Leufkens H.
    Nat Rev Drug Discov; 2010 Feb 17; 9(2):99-100. PubMed ID: 20118959
    [No Abstract] [Full Text] [Related]

  • 17. Industry and academia in transition.
    Kennedy D.
    Science; 2003 Nov 21; 302(5649):1293. PubMed ID: 14631000
    [No Abstract] [Full Text] [Related]

  • 18. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
    Liyanage SS, Raina Macintyre C.
    Health Info Libr J; 2006 Sep 21; 23(3):214-22. PubMed ID: 16911128
    [Abstract] [Full Text] [Related]

  • 19. A new era of hope for the world's most neglected diseases.
    The PLoS Medicine Editors.
    PLoS Med; 2005 Sep 21; 2(9):e323. PubMed ID: 16138790
    [Abstract] [Full Text] [Related]

  • 20. Funding medical and health-related research in the public interest.
    Baird PA.
    CMAJ; 1996 Aug 01; 155(3):299-301. PubMed ID: 8705910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.